$10.310
-0.167 (-1.62%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Design Therapeutics Inc (DSGN) Moving Averages Convergence Divergence (MACD) indicator is -0.85, suggesting DSGN is Strong sell.
Design Therapeutics Inc (DSGN) 20-Day simple moving average is 11.65, while Design Therapeutics Inc (DSGN) share price is $—, making it Sell.
Design Therapeutics Inc (DSGN) 60-Day simple moving average is 13.32, while Design Therapeutics Inc (DSGN) share price is $—, making it Sell.
Technical Analysis for DSGN
AI Technical DSGNAs of 2026-10-17, the technical board for Design Therapeutics Inc (DSGN) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $10.64 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 36.963, MACD stands at -0.852 (Sell), Stochastic %K stands at 28.866, Stochastic %D stands at 21.342 and CCI stands at -86.069.
DSGN trades below the 60-day SMA (13.32) and below the 200-day SMA (12.10). Immediate resistance sits at Classic R1 12.43, then R2 13.99. Support sits at Classic S1 9.39, then S2 7.91.
Design Therapeutics Inc (DSGN) Support & Resistance Level
Design Therapeutics Inc (DSGN) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 36.963 |
| STOCHk_14_3_3 | 28.866 |
| STOCHd_14_3_3 | 21.342 |
| CCI_20 | -86.069 |
| AO_5_34 | -2.463 |
| MOM_10 | -1.780 |
| MACD_12_26_9 | -0.852 |
Design Therapeutics Inc (DSGN) Relative Strength Index (RSI_14) is 36.963, creating a Neutral signal.
Design Therapeutics Inc (DSGN) Stochastic %K is 28.866, creating a Neutral signal.
Design Therapeutics Inc (DSGN) Stochastic %D is 21.342, creating a Neutral signal.
Design Therapeutics Inc (DSGN) CCI_20 is -86.069, creating a Neutral signal.
Design Therapeutics Inc (DSGN) Awesome Oscillator (AO) is -2.463, creating a Sell signal.
Design Therapeutics Inc (DSGN) Momentum (MOM) is -1.780, creating a Sell signal.
Design Therapeutics Inc (DSGN) Moving Average Convergence Divergence (MACD) is -0.852, creating a Sell signal.
Design Therapeutics Inc (DSGN) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 10.188 | Buy |
| MA_10 | 10.865 | Sell |
| MA_20 | 11.654 | Sell |
| MA_60 | 13.316 | Sell |
| MA_200 | 12.102 | Sell |
| MA_250 | 11.325 | Sell |
Design Therapeutics Inc (DSGN) 5-Day simple moving average is 10.188, while Design Therapeutics Inc (DSGN) share price is $, making it a Buy.
Design Therapeutics Inc (DSGN) 10-Day simple moving average is 10.865, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
Design Therapeutics Inc (DSGN) 20-Day simple moving average is 11.654, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
Design Therapeutics Inc (DSGN) 60-Day simple moving average is 13.316, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
Design Therapeutics Inc (DSGN) 200-Day simple moving average is 12.102, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
Design Therapeutics Inc (DSGN) 250-Day simple moving average is 11.325, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.